{"id":"argipressin","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Asthma","Chronic glomerulonephritis","Disorder of coronary artery","Epilepsy","Heart failure","Hypertensive disorder","Migraine","Uremia"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL2108986","moleculeType":"Protein"},"aliases":["Arg"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Oxytocin receptor, Vasopressin V1a receptor, Vasopressin V1b receptor"},"_scrapedAt":"2026-03-28T00:17:58.638Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Hereditary factor VIII deficiency disease","diseaseId":"hereditary-factor-viii-deficiency-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nocturnal enuresis","diseaseId":"nocturnal-enuresis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Partial Central Diabetes Insipidus","diseaseId":"partial-central-diabetes-insipidus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"von Willebrand disorder","diseaseId":"von-willebrand-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04569591","phase":"NA","title":"DDAVP for Pituitary Adenoma","status":"RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2026-03-09","conditions":"Cushing's Disease, Pituitary Adenoma","enrollment":22},{"nctId":"NCT06337838","phase":"PHASE3","title":"Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2025-06-09","conditions":"Chronic Kidney Diseases, Acute Kidney Injury, Bleeding","enrollment":100},{"nctId":"NCT07292753","phase":"NA","title":"Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-12-15","conditions":"Nocturnal Enuresis, Vitamin D Deficiency","enrollment":90},{"nctId":"NCT05958342","phase":"PHASE2","title":"CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial","status":"RECRUITING","sponsor":"Jason Sperry","startDate":"2024-06-30","conditions":"Trauma, Hemorrhage","enrollment":1050},{"nctId":"NCT06709573","phase":"PHASE4","title":"Early Versus Late Adjunctive Vasopressin in Septic Shock","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-04-29","conditions":"Sepsis, Septic Shock","enrollment":300},{"nctId":"NCT07446933","phase":"PHASE2","title":"Vasopressin vs. Uterine Artery Clamping for Laparoscopic Cesarean Scar Niche Repair","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2024-03-20","conditions":"Cesarean Section Complications","enrollment":30},{"nctId":"NCT07438925","phase":"","title":"Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure Variation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Central Hospital, Nancy, France","startDate":"2025-12-22","conditions":"Hemodialysis","enrollment":71},{"nctId":"NCT07423156","phase":"PHASE3","title":"Tranexamic Acid vs Vasopressin in Placenta Previa Trial","status":"NOT_YET_RECRUITING","sponsor":"Allama Iqbal Medical College","startDate":"2026-03-01","conditions":"Placenta Previa","enrollment":58},{"nctId":"NCT06426407","phase":"","title":"Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2025-10-01","conditions":"Shock, Septic","enrollment":2},{"nctId":"NCT07276152","phase":"NA","title":"Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation Technology","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2026-01-09","conditions":"Sonic Augmentation Technology","enrollment":22},{"nctId":"NCT06344442","phase":"PHASE3","title":"Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-04-16","conditions":"Acute Kidney Injury Post Liver Transplantation","enrollment":304},{"nctId":"NCT05824767","phase":"PHASE4","title":"Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2023-04-17","conditions":"Septic Shock, Vasodilatory Shock","enrollment":40},{"nctId":"NCT06464510","phase":"PHASE3","title":"Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2024-11-21","conditions":"Septic Shock","enrollment":2800},{"nctId":"NCT05738148","phase":"PHASE1","title":"Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2023-11-27","conditions":"Cardiac Arrest Neonatal","enrollment":20},{"nctId":"NCT05190744","phase":"PHASE2","title":"Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-09-01","conditions":"Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus, Acquired Nephrogenic Diabetes Insipidus","enrollment":36},{"nctId":"NCT07063680","phase":"PHASE3","title":"Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2026-01","conditions":"Patients With Norepinephrine-refractory Vasoplegic Shock","enrollment":390},{"nctId":"NCT06771128","phase":"NA","title":"Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2024-11-01","conditions":"Nocturnal Enuresis in Children, Desmopressin, Monosymptomatic Nocturnal Enuresis","enrollment":398},{"nctId":"NCT06930300","phase":"NA","title":"Vasopressin in the Elderly: Physiological Changes in Neuroendocrine Function and Urinary Secretion in Healthy Aging","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-04-30","conditions":"Healthy Ageing","enrollment":32},{"nctId":"NCT02118467","phase":"PHASE4","title":"Vasoactive Drugs in Intensive Care Unit","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2014-05-15","conditions":"Shock","enrollment":836},{"nctId":"NCT07328529","phase":"PHASE2","title":"Inhibition of Aggressive Behavior in Participants With Fragile X Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Azevan Pharmaceuticals","startDate":"2026-03","conditions":"Aggressive Behavior in Fragile X Syndome","enrollment":80},{"nctId":"NCT06344143","phase":"","title":"Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2024-11-20","conditions":"Mild Autonomous Cortisol Secretion (MACS)","enrollment":20},{"nctId":"NCT06036004","phase":"PHASE2","title":"Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-01-08","conditions":"Central Diabetes Insipidus (cDI)","enrollment":112},{"nctId":"NCT07067866","phase":"PHASE3","title":"Weaning Approaches for Vasopressin in Sepsis","status":"RECRUITING","sponsor":"Hospital Nossa Senhora da Conceicao","startDate":"2025-10-01","conditions":"Septic Shock","enrollment":82},{"nctId":"NCT05568160","phase":"PHASE3","title":"Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2023-01-02","conditions":"Scheduled Cardiac Surgery With Extracorporeal Circulation, Vasoplegic Syndrome","enrollment":840},{"nctId":"NCT07286643","phase":"NA","title":"Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2026-01-01","conditions":"Cirrhosis, Liver, Cirrhotic Cardiomyopathy, Septic Shock","enrollment":140},{"nctId":"NCT07255378","phase":"","title":"Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication","status":"RECRUITING","sponsor":"Jamil Cedeño Mora","startDate":"2025-10-01","conditions":"Septic Shock","enrollment":1200},{"nctId":"NCT06542198","phase":"NA","title":"Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-09-10","conditions":"Polyuria-polydipsia Syndrome, Arginine Vasopressin Deficiency, Primary Polydipsia","enrollment":42},{"nctId":"NCT03422848","phase":"NA","title":"Hydration to Optimize Metabolism","status":"COMPLETED","sponsor":"Region Skane","startDate":"2018-04-24","conditions":"Glucose, High Blood","enrollment":797},{"nctId":"NCT06203847","phase":"NA","title":"The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2024-07-16","conditions":"Cardiac Arrest, Out-Of-Hospital Cardiac Arrest, Emergency Medical Services","enrollment":1344},{"nctId":"NCT07143266","phase":"","title":"Sleep Disorders in Hypothalamic and Pituitary Damage","status":"RECRUITING","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2025-09-01","conditions":"Hypopituitarism, Sleep Wake Disorders, Hypothalamic Diseases","enrollment":60},{"nctId":"NCT05766852","phase":"NA","title":"Potential Benefits of the Somatic Psychoeducational Intervention","status":"COMPLETED","sponsor":"University of Florida","startDate":"2023-10-23","conditions":"Work Related Stress","enrollment":31},{"nctId":"NCT07102615","phase":"PHASE4","title":"Intracervical Vasopressin","status":"RECRUITING","sponsor":"Prisma Health-Upstate","startDate":"2025-10-30","conditions":"Retained Products of Conception","enrollment":50},{"nctId":"NCT03707054","phase":"NA","title":"Vasopressin in Intraabdominal Pressure Elevation","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2017-04-28","conditions":"Intracranial Pressure Increase, Abdominal Compartment Syndrome","enrollment":16},{"nctId":"NCT06635629","phase":"PHASE2","title":"Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2024-12-12","conditions":"Cushing Syndrome","enrollment":140},{"nctId":"NCT06217562","phase":"PHASE4","title":"Vasopressin for Septic Shock Pragmatic Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Intermountain Health Care, Inc.","startDate":"2024-02-01","conditions":"Septic Shock","enrollment":2050},{"nctId":"NCT06605300","phase":"NA","title":"The Effects of Oxytocin and Vasopressin on Delta-beta Cross-frequency Coupling","status":"COMPLETED","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-10-02","conditions":"Healthy","enrollment":120},{"nctId":"NCT06808516","phase":"PHASE2","title":"Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-07-01","conditions":"Arginine Vasopressin Deficiency, Central Diabetes Insipidus, Oxytocin Deficiency","enrollment":42},{"nctId":"NCT07199894","phase":"PHASE3","title":"Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2024-12-01","conditions":"Nocturnal Enuresis in Children","enrollment":120},{"nctId":"NCT03204786","phase":"PHASE2, PHASE3","title":"Intranasal Vasopressin Treatment in Children With Autism","status":"COMPLETED","sponsor":"Stanford University","startDate":"2018-02-20","conditions":"Autism, Autism Spectrum Disorder, ASD","enrollment":157},{"nctId":"NCT04789148","phase":"PHASE1","title":"Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency","status":"RECRUITING","sponsor":"Elizabeth Austen Lawson","startDate":"2025-09-10","conditions":"Vasopressin Deficiency","enrollment":40},{"nctId":"NCT06361693","phase":"","title":"Descriptive Observational Study of Patient-performed Pre-oxygenation","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-10-14","conditions":"Anesthesia, ASA Physical Status I, ASA Physical Status II","enrollment":110},{"nctId":"NCT04592744","phase":"PHASE4","title":"Angiotensin 2 for AKI After OLT","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, Los Angeles","startDate":"2022-04-08","conditions":"Cirrhosis, Liver, End Stage Liver DIsease, Acute Kidney Injury","enrollment":30},{"nctId":"NCT06622187","phase":"PHASE4","title":"Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies","status":"ENROLLING_BY_INVITATION","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2024-08-14","conditions":"Bleeding, Transplant, Kidney, Desmopressin","enrollment":96},{"nctId":"NCT06502158","phase":"PHASE1","title":"Mifepristone vs Misoprostol","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2024-10-31","conditions":"Cervical Preparation","enrollment":94},{"nctId":"NCT07052084","phase":"PHASE3","title":"Systematic Adjunction of Vasopressine in Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2026-01","conditions":"Septic Shock","enrollment":120},{"nctId":"NCT03064568","phase":"PHASE4","title":"Rectal Misoprostol as a Hemostatic Agent During Abdominal Myomectomy","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2016-10-14","conditions":"Myomectomy; Surgical Blood Loss","enrollment":18},{"nctId":"NCT06821802","phase":"NA","title":"Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-04-14","conditions":"Hyponatremia, Syndrome of Inappropriate Antidiuresis","enrollment":70},{"nctId":"NCT06155812","phase":"PHASE2, PHASE3","title":"Multimodal Vasopressor Strategy in Septic Shock","status":"RECRUITING","sponsor":"University Medical Centre Maribor","startDate":"2023-12-23","conditions":"Shock, Septic","enrollment":80},{"nctId":"NCT04591990","phase":"PHASE3","title":"HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-05-27","conditions":"Postresuscitation Syndrome","enrollment":380},{"nctId":"NCT04682483","phase":"","title":"Cardiogenic Shock Working Group Registry","status":"RECRUITING","sponsor":"Tufts Medical Center","startDate":"2017-12-04","conditions":"Cardiogenic Shock","enrollment":5000},{"nctId":"NCT06020495","phase":"PHASE3","title":"Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-12-17","conditions":"Hyponatremia","enrollment":260},{"nctId":"NCT06676774","phase":"PHASE2","title":"Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-05-16","conditions":"Arginine Vasopressin Deficiency, Diabetes Insipidus","enrollment":42},{"nctId":"NCT03446456","phase":"PHASE1, PHASE2","title":"Vasopressin and Pain Perception in the Brain","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2018-09-17","conditions":"Acute Pain","enrollment":40},{"nctId":"NCT04463394","phase":"EARLY_PHASE1","title":"The Hemodynamic Effects of Vasopressin in Patients With Fontan Physiology","status":"COMPLETED","sponsor":"Stanford University","startDate":"2020-08-12","conditions":"Hypotension, Fontan Physiology","enrollment":28},{"nctId":"NCT05467033","phase":"PHASE3","title":"Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin","status":"RECRUITING","sponsor":"Medical University of Bialystok","startDate":"2022-09-01","conditions":"Kidney Biopsy","enrollment":424},{"nctId":"NCT06953297","phase":"","title":"Vasopressin Use in Septic Shock From Türkiye","status":"COMPLETED","sponsor":"Karadeniz Technical University","startDate":"2024-01-01","conditions":"Septic Shock, Vasodilatory Shock, Critical Illness Sepsis, Severe","enrollment":146},{"nctId":"NCT06934798","phase":"PHASE4","title":"Inotropic Effects of Vasopressin Versus Noradrenaline In Patients With Vasoplegic Syndrome After Cardiac Surgery","status":"RECRUITING","sponsor":"University of Sao Paulo","startDate":"2024-04-01","conditions":"Vasoplegic Syndrome of Cardiac Surgery","enrollment":350},{"nctId":"NCT06547892","phase":"PHASE2","title":"Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2025-04-10","conditions":"Critical Illness","enrollment":60},{"nctId":"NCT06234592","phase":"NA","title":"The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock","status":"RECRUITING","sponsor":"King's College Hospital NHS Trust","startDate":"2024-01-05","conditions":"Septic Shock, Acute Kidney Injury","enrollment":45},{"nctId":"NCT02785224","phase":"","title":"Arterial Pressure and Stress-Dose Steroids in Cardiac Arrest.","status":"WITHDRAWN","sponsor":"University of Athens","startDate":"2025-12","conditions":"Cardiac Arrest","enrollment":""},{"nctId":"NCT04501861","phase":"PHASE3","title":"Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2020-11-05","conditions":"Cardiac Disease","enrollment":153},{"nctId":"NCT05506319","phase":"PHASE4","title":"Hypotension in the Weaning From Vasopressor Drugs","status":"COMPLETED","sponsor":"Hospital Nossa Senhora da Conceicao","startDate":"2022-05-01","conditions":"Septic Shock","enrollment":78},{"nctId":"NCT05293041","phase":"PHASE4","title":"Argipressin's Influence on Blood Loss During Hepatic Resection","status":"COMPLETED","sponsor":"Kristina Svennerholm","startDate":"2022-03-27","conditions":"Colon Cancer Liver Metastasis, Inflammatory Response, Vasopressin Causing Adverse Effects in Therapeutic Use","enrollment":248},{"nctId":"NCT06853574","phase":"NA","title":"Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"General and Teaching Hospital Celje","startDate":"2025-02","conditions":"Sepsis, Septic Shock","enrollment":30},{"nctId":"NCT06789705","phase":"NA","title":"Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-01-27","conditions":"Central Diabetes Insipidus","enrollment":24},{"nctId":"NCT06460948","phase":"EARLY_PHASE1","title":"Identifying Oxytocin Deficiency in Adults With Pituitary Disease","status":"RECRUITING","sponsor":"Elizabeth Austen Lawson","startDate":"2024-11-13","conditions":"Arginine Vasopressin Deficiency, Oxytocin Deficiency","enrollment":32},{"nctId":"NCT06419075","phase":"PHASE4","title":"Tranexamic Acid in Vaginal Reconstructive Surgery","status":"WITHDRAWN","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2024-07-01","conditions":"Pelvic Organ Prolapse","enrollment":""},{"nctId":"NCT06772584","phase":"NA","title":"Ginko Biloba Versus Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2024-01-01","conditions":"Enuresis, Nocturnal","enrollment":90},{"nctId":"NCT04329975","phase":"","title":"Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2020-05-19","conditions":"Nocturia Due to Nocturnal Polyuria","enrollment":1087},{"nctId":"NCT02975999","phase":"PHASE2, PHASE3","title":"Use of Vasopressin Following the Fontan Operation","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2016-12","conditions":"Pleural Effusion, Single-ventricle","enrollment":12},{"nctId":"NCT05507476","phase":"NA","title":"Nasal Desmopressin Versus Topical Epinephrine in Endonasal Dacryocystorhinostomy","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2022-09-01","conditions":"Anesthesia","enrollment":52},{"nctId":"NCT06556472","phase":"NA","title":"Safety and Efficacy of Continuous Infusion of Terlipressin With Norepinephrine Versus Norepinephrine Alone in Improving Outcomes of Acute Kidney Injury in Acute on Chronic Liver Failure With Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2024-08-15","conditions":"Acute on Chronic Liver Failure","enrollment":126},{"nctId":"NCT04950270","phase":"","title":"Copeptin Kinetics in Critically Ill Patients With Posterior Reversible Encephalopathy Syndrome","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2022-06-18","conditions":"Posterior Reversible Encephalopathy Syndrome","enrollment":24},{"nctId":"NCT06499467","phase":"","title":"Norepinephrine Equivalent Dose of Vasopressin, Phenylephrine and Epinephrine in Septic Shock","status":"RECRUITING","sponsor":"Sanjay Gandhi Postgraduate Institute of Medical Sciences","startDate":"2024-07-12","conditions":"Septic Shock","enrollment":100},{"nctId":"NCT06422975","phase":"","title":"Registry of Patients in Shock Treated With Vasopressin","status":"RECRUITING","sponsor":"Hospital Universitario 12 de Octubre","startDate":"2024-07-09","conditions":"Vasopressin Causing Adverse Effects in Therapeutic Use, Shock, Vasopressor Adverse Reaction","enrollment":500},{"nctId":"NCT06498856","phase":"","title":"Saline Infusion Test in Hyponatremia","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Akershus","startDate":"2024-07","conditions":"Hyponatremia","enrollment":100},{"nctId":"NCT06471231","phase":"PHASE4","title":"Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock","status":"RECRUITING","sponsor":"Azienda Usl di Bologna","startDate":"2024-05-15","conditions":"Septic Shock, Renal Function Replacement","enrollment":264},{"nctId":"NCT04420585","phase":"PHASE4","title":"Desmopressin for Bedwetting in Children With SCD","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2020-07-07","conditions":"Nocturnal Enuresis, Anemia, Sickle Cell","enrollment":8},{"nctId":"NCT06285006","phase":"NA","title":"Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis","status":"RECRUITING","sponsor":"Al-Azhar University","startDate":"2024-02-23","conditions":"Nocturnal Enuresis","enrollment":50},{"nctId":"NCT06376318","phase":"","title":"Shock and Acute Conditions OutcOmes Platform","status":"ACTIVE_NOT_RECRUITING","sponsor":"Saint-Louis Hospital, Paris, France","startDate":"2024-01-01","conditions":"Circulatory Shock, Sepsis, Cardiogenic Shock","enrollment":1000},{"nctId":"NCT06329063","phase":"NA","title":"Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-03-05","conditions":"Healthy","enrollment":80},{"nctId":"NCT06329037","phase":"NA","title":"The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-03-05","conditions":"Healthy","enrollment":80},{"nctId":"NCT04602767","phase":"PHASE4","title":"Low Dose Vasopressin vs Phenylephrine in Cardiac Surgery","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2020-10-15","conditions":"Acute Kidney Injury","enrollment":300},{"nctId":"NCT04103034","phase":"PHASE1","title":"A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers","status":"COMPLETED","sponsor":"Band Therapeutics","startDate":"2019-10-07","conditions":"Cerebrovascular Stroke, Large-Artery Atherosclerosis (Embolus/Thrombosis), Intracranial Arteriosclerosis","enrollment":112},{"nctId":"NCT06255366","phase":"PHASE4","title":"Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion","status":"NOT_YET_RECRUITING","sponsor":"Chengdu University of Traditional Chinese Medicine","startDate":"2024-03-28","conditions":"Lumbar Spondylolisthesis, Arthrosis; Spine","enrollment":126},{"nctId":"NCT05193370","phase":"PHASE4","title":"Angiotensin II vs. Vasopressin in Septic Shock","status":"WITHDRAWN","sponsor":"University of New Mexico","startDate":"2022-01-03","conditions":"Septic Shock","enrollment":""},{"nctId":"NCT06302998","phase":"PHASE2","title":"Dexmedetomidine and Vasopressin in Septic Shock","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2024-06","conditions":"Sepsis, Septic Shock","enrollment":260},{"nctId":"NCT04053478","phase":"NA","title":"Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study","status":"RECRUITING","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2019-07-08","conditions":"Hypotension","enrollment":144},{"nctId":"NCT06290596","phase":"PHASE4","title":"Vasopressin Versus Tranexamic Acid for Control of Blood Loss Related to Abdominal Hysterectomy","status":"NOT_YET_RECRUITING","sponsor":"Al-Azhar University","startDate":"2024-04-01","conditions":"Uterine Surgery","enrollment":387},{"nctId":"NCT06265259","phase":"PHASE4","title":"Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients","status":"RECRUITING","sponsor":"University of Thessaly","startDate":"2023-12-15","conditions":"Circulatory Shock","enrollment":145},{"nctId":"NCT06268587","phase":"","title":"A Before and After Study Studying the Impact of an Analgesia Protocol After Discharge From Outpatient Surgery","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Liege","startDate":"2019-09-01","conditions":"Postoperative Pain, Outpatient Surgery","enrollment":1423},{"nctId":"NCT03815344","phase":"PHASE4","title":"Combined Vaginal Misoprostol and Perivascular Vasopressin","status":"COMPLETED","sponsor":"Antonios Likourezos","startDate":"2017-04-26","conditions":"Leiomyoma, Laparoscopy, Uterine Myomectomy","enrollment":74},{"nctId":"NCT06185361","phase":"NA","title":"Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.","status":"UNKNOWN","sponsor":"Fayoum University Hospital","startDate":"2022-12-01","conditions":"Nocturnal Enuresis, Enuresis, Enuresis, Nocturnal","enrollment":60},{"nctId":"NCT03602521","phase":"NA","title":"Reactivity of Patients With Borderline Personality Disorder to an Ecological Interpersonal Stress","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2019-02-27","conditions":"Female, Borderline Personality Disorder","enrollment":116},{"nctId":"NCT06165185","phase":"NA","title":"Water and Coffee Intervention in Humans","status":"COMPLETED","sponsor":"Region Skane","startDate":"2011-01-01","conditions":"Excess Intake of Macronutrients, Excess Intake of Micronutrients, Vasopressin Low","enrollment":39},{"nctId":"NCT05774067","phase":"NA","title":"Noradrenaline Versus Glypressin for Prevention of Hypotension After Deflation of Tourniquet in Knee Arthroplasty","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-12-01","conditions":"Norepinephrine, Glypressin, Tourniquet Deflation, Hypotension","enrollment":135},{"nctId":"NCT04233606","phase":"NA","title":"Influence of Osmotic Stimulation of Vasopressin on Autonomic Function","status":"WITHDRAWN","sponsor":"University of North Carolina, Greensboro","startDate":"2023-11","conditions":"Water Stress, Body Water Dehydration","enrollment":""},{"nctId":"NCT06125184","phase":"NA","title":"Effect of Vasopressin on Kidney and Cardiac Function in Septic Shock","status":"UNKNOWN","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2022-11-01","conditions":"Kidney Injury, Acute, Cardiac Function Failed","enrollment":50},{"nctId":"NCT03483753","phase":"PHASE2, PHASE3","title":"Vasopressin or Norepinephrine in Vasoplegic Shock After Non-cardiac Surgery","status":"WITHDRAWN","sponsor":"University of Sao Paulo","startDate":"2019-01","conditions":"Circulatory Shock, Non-cardiac Surgery","enrollment":""},{"nctId":"NCT06055907","phase":"","title":"Influence of Vasopressors on Anti-Xa Activity in Critically Ill Patients","status":"UNKNOWN","sponsor":"Medical University of Gdansk","startDate":"2023-05-15","conditions":"Critical Illness, Thrombosis","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":24,"therapeuticAreas":["Metabolic"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Argipressin","genericName":"Argipressin","companyName":"Kristina Svennerholm","companyId":"kristina-svennerholm","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}